| |
A Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of INX-08189, a Nucleotide Polymerase Inhibitor, in Healthy Subjects
|
| |
| |
EASL 2011
A Barry1,J Patti1, M Matson2, B Boehlecke3, E Wenzel1, H Pentikis4, J Alam1, and G Henson1
1Inhibitex, Inc. Alpharetta, GA, 2Prism Research, St. Paul, MN, 3Rho Inc., Chapel Hill, NC, 4SAJE Consulting, Baltimore, MD
|
|
| |
| |
|
|
|
